Value-based insurance plans can up Rx adherence

Value-based insurance plans can up rx adherence

(HealthDay)—Value-based insurance design (VBID) plans with certain features aside from solely lowering cost sharing can increase medication adherence, according to a study published in the March issue of Health Affairs.

Niteesh K. Choudhry, M.D., Ph.D., from Harvard University in Boston, and colleagues evaluated 76 VBID plans introduced by a large pharmacy benefit manager from 2007 to 2010.

The researchers found that VBID plans that made a significantly greater impact on adherence were more generous, targeted high-risk patients, offered , did not offer disease management programs, and made the benefit available only for medication ordered by mail. The effects of these features were as large as four to five percentage points, compared to plans without these characteristics.

"These findings can provide guidance for the structure of future VBID plans," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: Health Affairs

Copyright © 2014 HealthDay. All rights reserved.

Citation: Value-based insurance plans can up Rx adherence (2014, March 6) retrieved 25 July 2024 from https://medicalxpress.com/news/2014-03-value-based-rx-adherence.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Can insurers save money by providing free diabetes-related medications and supplies?

 shares

Feedback to editors